高级检索
当前位置: 首页 > 详情页

Role of the PI3K/Akt signaling pathway in liver ischemia reperfusion injury: a narrative review.

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE ◇ 预警期刊

单位: [1]Institute of Organ Transplantation, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan,China [2]Key Laboratory of Organ, Wuhan, China [3]Transplantation, Ministry of Education, Wuhan, China [4]NHC Key Laboratory of OrganTransplantation, Wuhan, China [5]Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan, China [6]Departmentof Urology, the First Affiliated Hospital of Anhui Medical University, Hefei, China [7]Institute of Urology, Anhui Medical University, Hefei, China [8]Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei, China
出处:
ISSN:

关键词: Phosphatidylinositol-3-kinase/protein kinase B (PI3K/Akt) liver ischemia reperfusion injury (LIRI) oxidative stress apoptosis autophagy

摘要:
To explore the role of phosphatidylinositol-3-kinase/protein kinase B and alpha serine/threonine protein kinase PI3K/PKB (also known as PI3K/Akt) signaling pathway in liver ischemia reperfusion injury.The PI3K/Akt signaling pathway is one of the major signal transduction pathways that regulates numerous cellular activities in vivo. The main functions of this pathway include induction of stem cell differentiation and metastasis, promotion of cell proliferation, inhibition of apoptosis, and regulation of tissue inflammation, tumor growth, and invasion. Liver ischemia reperfusion injury is an inevitable clinical problem that can occur during liver transplantation, liver resection, and various circulatory shock events, and it is one of the primary reasons for postoperative liver dysfunction, and poor disease outcome and patient prognosis. In recent years, it has been found that PI3K/Akt signaling pathway is closely related to liver ischemia reperfusion injury.In this review, a large number of relevant literatures were collected to explain the biological basis of PI3K/Akt signaling pathway and its role in liver ischemia reperfusion injury. The review was based on a PubMed search using the terms "liver ischemia reperfusion injury", "PI3K/Akt signaling pathway", and "PI3K/Akt signaling pathway AND liver ischemia reperfusion injury", so as to understand the complex interaction between them.Activated PI3K/Akt signaling pathway can exert anti-inflammatory, antioxidant stress, antiapoptosis and autophagy regulation effects through downstream related targeted pathways and proteins, thus alleviating liver ischemia-reperfusion injury. Therefore, the regulation of PI3K/Akt signaling pathway is expected to become an effective targeted pathway for clinical prevention and alleviation of liver ischemia reperfusion injury.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 4 区 医学
小类 | 4 区 卫生保健与服务
最新[2025]版:
JCR分区:
出版当年[2020]版:
Q3 HEALTH CARE SCIENCES & SERVICES
最新[2023]版:

影响因子: 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者单位: [1]Institute of Organ Transplantation, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan,China [2]Key Laboratory of Organ, Wuhan, China [3]Transplantation, Ministry of Education, Wuhan, China [4]NHC Key Laboratory of OrganTransplantation, Wuhan, China [5]Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan, China
通讯作者:
通讯机构: [1]Institute of Organ Transplantation, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan,China [2]Key Laboratory of Organ, Wuhan, China [3]Transplantation, Ministry of Education, Wuhan, China [4]NHC Key Laboratory of OrganTransplantation, Wuhan, China [5]Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan, China [*1]Institute of Organ Transplantation, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:428 今日访问量:0 总访问量:412 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)